Despite advances in antifungal therapies, many problems remain to be solved for most antifungal drugs available. Genital isolates of Candida have been reported to be slightly susceptible to one or more of the commonly used azoles. Mechanisms of resistance to azole drugs have been described for C. albicans , all based on altered gene expression and appearing to frequently accumulate in individual clinical isolates for stepwise development of high-level drug resistance